The role of local antiseptics in the prevention of coronavirus infection during endonasal interventions on the lacrimal ducts

Close metadata

OBJECTIVE

Generalization and analysis of available data concerning local antiseptic therapy for the prevention of coronavirus infection during endonasal interventions on the lacrimal tract.

MATERIAL AND METHODS

The search for literature sources was carried out using MEDLINE search engines and the Russian Science Citation Index for queries with the keywords “COVID-19”, “coronavirus infection”, “antiseptics”, “protocol for otorhinolaryngological operations”, “dacryosurgical operations” and similar in various combinations.

RESULTS

It has been shown that during endonasal operations on the lacrimal tract, the number of risk factors for infection increases, since these procedures are aerosol-generating, and contact occurs not only with the nasal mucosa, but also with the lacrimal fluid, in which the coronavirus is also replicated. The data on the effectiveness of various antiseptics are summarized, the analysis of the possibility of their use in preoperative preparation for endonasal interventions on the lacrimal tract from the point of view of efficacy and safety is carried out. Information is provided on the proprietary protocol for the use of antiseptics to prevent the spread of coronavirus infection during endonasal dacryocystorhinostomy. It is shown that the preventive use of local disinfectants reduces the number of viral particles on the nasal mucosa, which leads to a decrease in contamination of the surrounding space. Among the available and studied antiseptics, the most suitable is povidone-iodine, which can be used in concentrations up to 1.25% to irrigate the nasal mucosa before surgery with an exposure of 30-60 sec. When performing operations on the lacrimal pathways, it is also advisable to carry out antiseptic treatment of the conjunctival cavity with a 5% solution of povidone-iodine and rinse the lacrimal pathways before the operation with povidone-iodine in a concentration of 0.4%.

CONCLUSION

To date, information has been obtained that makes it advisable to use antiseptics before performing endonasal aerosol-generating interventions, in particular endonasal dacryocystorhinostomies and recanalization of the tear ducts.

Keywords:

COVID-19

disinfectants

endonasal operations on lacrimal tracts

Authors:

Yartsev V.D.

Krasnov Research Institute of Eye Diseases

ORCID: 0000-0003-2990-8111

Atkova E.L.

Krasnov Research Institute of Eye Diseases

ORCID: 0000-0001-9875-6217

Received:

03.11.2020

Accepted:

12.01.2021

List of references:

Fennessy BG, Harney M, O’Sullivan MJ, Timon C. Antimicrobial prophylaxis in otorhinolaryngology/head and neck surgery. Clinical Otolaryngology. 2007;32(3):204-207. https://doi.org/10.1111/j.1365-2273.2007.01440.x.
Karaman E, Alimoglu Y, Aygun G, Kilic E, Yagiz C. Effect of septoplasty and per-operative antibiotic prophylaxis on nasal flora. B-ENT. 2012;8(1):13-19.
Kryukov AI, Eliseev OV. Pre- and intraoperative preparation of patients with pyoinflammatory diseases of the ear, pharynx and paranasal sinuses. Vestnik otorinolaringologii. 2004;1:39-41. (In Russ.).
Georgievsky IV, Lopatin AS. Local antibacterial preoperative prophylaxis in rhinosurgery. Rossijskaya rinologiya. 2006;4:17-21. (In Russ.).
Rusetsky YuYu, Sedykh TK, Chernyshenko IO, Martyanova NM. Effective antiseptic washing of surgical site during endoscopic adenotomy Rossijskaya rinologiya. 2013;21(1):11-15. (In Russ.).
Al-Jabir A, Kerwan A, Nicola M, Alsafi Z, Khan M, Sohrabi C, O’Neill N, Iosifidis C, Griffin M, Mathew G, Agha R. Impact of the Coronavirus (COVID-19) pandemic on surgical practice — Part 2 (surgical prioritisation). International Journal of Surgery. 2020;79:233-248. https://doi.org/10.1016/j.ijsu.2020.05.002
Di Saverio S, Pata F, Gallo G, Carrano F, Scorza A, Sileri P, Smart N, Spinelli A, Pellino G. Coronavirus pandemic and colorectal surgery: practical advice based on the Italian experience. Colorectal Disease. 2020;22(6):625-634. https://doi.org/10.1111/codi.15056
Patel ZM, Fernandez-Miranda J, Hwang PH, Nayak JV, Dodd R, Sajjadi H, Jackler RK. Letter: Precautions for Endoscopic Transnasal Skull Base Surgery During the COVID-19 Pandemic. Neurosurgery. 2020;87(1):66-67. https://doi.org/10.1093/neuros/nyaa125
Tan L, Kovoor JG, Williamson P, Tivey DR, Babidge WJ, Collinson TG, Hewett PJ, Hugh TJ, Padbury RTA, Langley SJ, Maddern GJ. Personal protective equipment and evidence-based advice for surgical departments during COVID-19. ANZ Journal of Surgery. 2020;90(9):1566-1572. https://doi.org/10.1111/ans.16194
Kleiboeker S, Cowden S, Grantham J, Nutt J, Tyler A, Berg A, Altrich M. SARS-CoV-2 viral load assessment in respiratory samples. Journal of Clinical Virology. 2020;129:104439. https://doi.org/10.1016/j.jcv.2020.104439
Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, Yu J, Kang M, Song Y, Xia J, Guo Q, Song T, He J, Yen HL, Peiris M, Wu J. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. The New England Journal of Medicine. 2020; 382(12):1177-1179. https://doi.org/10.1056/NEJMc2001737
Mick P, Murphy R. Aerosol-generating otolaryngology procedures and the need for enhanced PPE during the COVID-19 pandemic: a literature review. Journal of Otolaryngology — Head and Neck Surgery. 2020;49(1):29. https://doi.org/10.1186/s40463-020-00424-7
Thamboo A, Lea J, Sommer DD, Sowerby L, Abdalkhani A, Diamond C, Ham J, Heffernan A, Cai Long M, Phulka J, Wu YQ, Yeung P, Lammers M. Clinical evidence based review and recommendations of aerosol generating medical procedures in otolaryngology — head and neck surgery during the COVID-19 pandemic. Journal of Otolaryngology — Head and Neck Surgery. 2020;49(1):28. https://doi.org/10.1186/s40463-020-00425-6
Gralton J, Tovey E, McLaws ML, Rawlinson WD. The role of particle size in aerosolised pathogen transmission: A review. The Journal of Infection. 2011;62(1):1-13. https://doi.org/10.1016/j.jinf.2010.11.010
an Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, Tamin A, Harcourt JL, Thornburg NJ, Gerber SI, Lloyd-Smith JO, de Wit E, Munster VJ. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. The New England Journal of Medicine. 2020;382(16):1564-1567. https://doi.org/10.1056/NEJMc2004973
Ali MJ. A Surgical Protocol to Mitigate the SARS-CoV-2 Transmission Using Multifocal Povidone-Iodine Applications in Lacrimal Surgeries During Coronavirus Disease 2019 (COVID-19) Pandemic. Ophthalmic Plastic and Reconstructive Surgery. 2020;36(4): 416-417. https://doi.org/10.1097/IOP.0000000000001746
Ong SWX, Tan YK, Chia PY, Lee TH, Ng OT, Wong MSY, Marimuthu K. Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient. JAMA. 2020;323(16):1610-1612. https://doi.org/10.1001/jama.2020.3227
Parhar HS, Tasche K, Brody RM, Weinstein GS, O’Malley BW, Shanti RM, Newman JG. Topical preparations to reduce SARS-CoV-2 aerosolization in head and neck mucosal surgery. Head and Neck. 2020;42(6):1268-1272. https://doi.org/10.1002/hed.26200
Nikonov EL, Kryukov AI, Kunelskaya NL, Tsarapkin GYu, Vasilenko IP, Bondareva GP, Nosulya EV, Sudarev PA, Bessarab TP, Tovmasyan AS, Yanyushkina ES, Timofeeva MG, Kishinevsky AE, Chalov DM, Gorovaya EV. ENT care in the context of the new coronavirus infection COVID-19. Vestnik otorinolaringologii. 2020;85(4):70-76. (In Russ.). https://doi.org/10.17116/otorino20208504170
Couloigner V, Schmerber S, Nicollas R, Coste A, Barry B, Makeieff M, Boudard P, Bequignon E, Morel N, Lescanne E; French Society of Otorhinolaryngology, Head, Neck Surgery (SFORL); French College of Otorhinolaryngology, Head, Neck Surgery; French Syndicate of ENT Specialists (SNORL). COVID-19 and ENT Surgery. European Annals of Otorhinolaryngology, Head and Neck Diseases. 2020;137(3):161-166. https://doi.org/10.1016/j.anorl.2020.04.012
Chari DA, Workman AD, Chen JX, Jung DH, Abdul-Aziz D, Kozin ED, Remenschneider AK, Lee DJ, Welling DB, Bleier BS, Quesnel AM. Aerosol Dispersion During Mastoidectomy and Custom Mitigation Strategies for Otologic Surgery in the COVID-19 Era. Otolaryngology — Head and Neck Surgery. 2020;194599820941835. https://doi.org/10.1177/0194599820941835
Sorbello M, Rosenblatt W, Hofmeyr R, Greif R, Urdaneta F. Aerosol boxes and barrier enclosures for airway management in COVID-19 patients: A scoping review and narrative synthesis. British Journal of Anaesthesia. 2020;125(6):880-894. https://doi.org/10.1016/j.bja.2020.08.038
Ananth L, Hosamani P. Management of ENT Surgical Emergencies Amidst COVID-19 Lockdown: Our Experience in a Tertiary Referral Hospital. Indian Journal of Otolaryngology and Head and Neck Surgery. 2020;73(2):1-8. https://doi.org/10.1007/s12070-020-01987-7
Krajewska Wojciechowska J, Krajewski W, Zub K, Zatonski T. Review of practical recommendations for otolaryngologists and head and neck surgeons during the COVID-19 pandemic. Auris Nasus Larynx. 2020;47(4):544-558. https://doi.org/10.1016/j.anl.2020.05.022
Ti LK, Ang LS, Foong TW, Ng BSW. What we do when a COVID-19 patient needs an operation: operating room preparation and guidance. Canadian Journal of Anaesthesia. 2020;67(6):756-758. https://doi.org/10.1007/s12630-020-01617-4
Dexter F, Parra MC, Brown JR, Loftus RW. Perioperative COVID-19 Defense: An Evidence-Based Approach for Optimization of Infection Control and Operating Room Management. Anesthesia and Analgesia. 2020;131(1):37-42. https://doi.org/10.1213/ANE.0000000000004829
Frank S, Capriotti J, Brown SM, Tessema B. Povidone-Iodine Use in Sinonasal and Oral Cavities: A Review of Safety in the COVID-19 Era. Ear, Nose, and Throat Journal. 2020;145561320932318. https://doi.org/10.1177/0145561320932318
Khan MM, Parab SR. 0.5% povidone iodine irrigation in otorhinolaryngology surgical practice during COVID 19 pandemic. American Journal of Otolaryngology. 2020;41(6):102687. https://doi.org/10.1016/j.amjoto.2020.102687
Khan MM, Parab SR, Paranjape M. Repurposing 0.5% povidone iodine solution in otorhinolaryngology practice in Covid 19 pandemic. American Journal of Otolaryngology. 2020;41(5):102618. https://doi.org/10.1016/j.amjoto.2020.102618
Mady LJ, Kubik MW, Baddour K, Snyderman CH, Rowan NR. Consideration of povidone-iodine as a public health intervention for COVID-19: Utilization as “Personal Protective Equipment” for frontline providers exposed in high-risk head and neck and skull base oncology care. Oral Oncology. 2020;105:104724. https://doi.org/10.1016/j.oraloncology.2020.104724
Loon SC, Teoh SC, Oon LL, Se-Thoe SY, Ling AE, Leo YS, Leong HN. The severe acute respiratory syndrome coronavirus in tears. The British Journal of Ophthalmology. 2004;88(7):861-863. https://doi.org/10.1136/bjo.2003.035931
Wu P, Duan F, Luo C, Liu Q, Qu X, Liang L, Wu K. Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmology. 2020;138(5):575-578. https://doi.org/10.1001/jamaophthalmol.2020.1291
Zhang X, Chen X, Chen L, Deng C, Zou X, Liu W, Yu H, Chen B, Sun X. The evidence of SARS-CoV-2 infection on ocular surface. The Ocular Surface. 2020;18(3):360-362. https://doi.org/10.1016/j.jtos.2020.03.010
Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. The Journal of Hospital Infection. 2020;104(3):246-251. https://doi.org/10.1016/j.jhin.2020.01.022
Kampf G, Todt D, Pfaender S, Steinmann E. Corrigendum to “Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents” [J Hosp Infect 104 (2020) 246-251]. The Journal of Hospital Infection. 2020;105(3):587. https://doi.org/10.1016/j.jhin.2020.06.001
Bidra AS, Pelletier JS, Westover JB, Frank S, Brown SM, Tessema B. Comparison of In Vitro Inactivation of SARS CoV-2 with Hydrogen Peroxide and Povidone-Iodine Oral Antiseptic Rinses. Journal of Prosthodontics. 2020;29(7):599-603. https://doi.org/10.1111/jopr.13220.
Sapkota M, Wyatt TA. Alcohol, Aldehydes, Adducts and Airways. Biomolecules. 2015;5(4):2987-3008. https://doi.org/10.3390/biom5042987
Vetter A, Augustijns P, Bernkop-Schnurch A. Solubilizing agents in nasal formulations and their effect on ciliary beat frequency. Toxicology In Vitro. 2012;26(1):150-156. https://doi.org/10.1016/j.tiv.2011.10.011
Workman AD, Cohen NA. The effect of drugs and other compounds on the ciliary beat frequency of human respiratory epithelium. American Journal of Rhinology and Allergy. 2014;28(6):454-464. https://doi.org/10.2500/ajra.2014.28.4092
Reimer K, Wichelhaus TA, Schafer V, Rudolph P, Kramer A, Wutzler P, Ganzer D, Fleischer W. Antimicrobial effectiveness of povidone-iodine and consequences for new application areas. Dermatology. 2002;204(Suppl 1):114-120. https://doi.org/10.1159/000057738
Kim JH, Rimmer J, Mrad N, Ahmadzada S, Harvey RJ. Betadine has a ciliotoxic effect on ciliated human respiratory cells. The Journal of Laryngology and Otology. 2015;129(Suppl 1):45-50. https://doi.org/10.1017/S0022215114002746
Ramezanpour M, Smith JLP, Psaltis AJ, Wormald PJ, Vreugde S. In vitro safety evaluation of a povidone-iodine solution applied to human nasal epithelial cells. International Forum of Allergy and Rhinology. 2020;10(10):1141-1148. https://doi.org/10.1002/alr.22575
Sato S, Miyake M, Hazama A, Omori K. Povidone-iodine-induced cell death in cultured human epithelial HeLa cells and rat oral mucosal tissue. Drug and Chemical Toxicology. 2014;37(3):268-275. https://doi.org/10.3109/01480545.2013.846364
Berkelman RL, Holland BW, Anderson RL. Increased bactericidal activity of dilute preparations of povidone-iodine solutions. Journal of Clinical Microbiology. 1982;15(4):635-639. https://doi.org/10.1128/JCM.15.4.635-639.1982
Pelletier JS, Tessema B, Frank S, Westover JB, Brown SM, Capriotti JA. Efficacy of Povidone-Iodine Nasal and Oral Antiseptic Preparations Against Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2). Ear, Nose, and Throat Journal. 2021; 100(2 Suppl):192S-196S. https://doi.org/10.1177/0145561320957237
Anderson DE, Sivalingam V, Kang AEZ, Ananthanarayanan A, Arumugam H, Jenkins TM, Hadjiat Y, Eggers M. Povidone-Iodine Demonstrates Rapid In Vitro Virucidal Activity Against SARS-CoV-2, The Virus Causing COVID-19 Disease. Infectious Diseases and Therapy. 2020;9(3):669-675. https://doi.org/10.1007/s40121-020-00316-3
Eggers M, Eickmann M, Zorn J. Rapid and Effective Virucidal Activity of Povidone-Iodine Products Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and Modified Vaccinia Virus Ankara (MVA). Infectious Diseases and Therapy. 2015;4(4):491-501. https://doi.org/10.1007/s40121-015-0091-9
Chorney SR, Rizzi MD, Dedhia K. Considerations for povidone-iodine antisepsis in pediatric nasal and pharyngeal surgery during the COVID-19 pandemic. American Journal of Otolaryngology. 2020;41(6):102737. https://doi.org/10.1016/j.amjoto.2020.102737
Carrim ZI, Mackie G, Gallacher G, Wykes WN. The efficacy of 5% povidone-iodine for 3 minutes prior to cataract surgery. European Journal of Ophthalmology. 2009;19(4):560-564. https://doi.org/10.1177/112067210901900407
Mino de Kaspar H, Chang RT, Singh K, Egbert PR, Blumenkranz MS, Ta CN. Prospective randomized comparison of 2 different methods of 5% povidone-iodine applications for anterior segment intraocular surgery. Archives of Ophthalmology. 2005;123(2):161-165. https://doi.org/10.1001/archopht.123.2.161
Koerner JC, George MJ, Meyer DR, Rosco MG, Habib MM. Povidone-iodine concentration and dosing in cataract surgery. Survey of Ophthalmology. 2018;63(6):862-868. https://doi.org/10.1016/j.survophthal.2018.05.002
Speaker MG, Menikoff JA. Prophylaxis of endophthalmitis with topical povidone-iodine. Ophthalmology. 1991;98(12):1769-1775. https://doi.org/10.1016/s0161-6420(91)32052-9
Vazirani J, Basu S. Role of topical, subconjunctival, intracameral, and irrigative antibiotics in cataract surgery. Current Opinion in Ophthalmology. 2013;24(1):60-65. https://doi.org/10.1097/ICU.0b013e32835a93be
Li B, Nentwich MM, Hoffmann LE, Haritoglou C, Kook D, Kampik A, Sheng M, Mino de Kaspar H. Comparison of the efficacy of povidone-iodine 1.0%, 5.0%, and 10.0% irrigation combined with topical levofloxacin 0,3% as preoperative prophylaxis in cataract surgery. Journal of Cataract and Refractive Surgery. 2013;39(7):994-1001. https://doi.org/10.1016/j.jcrs.2013.02.039
Nentwich MM, Rajab M, Ta CN, He L, Grueterich M, Haritoglou C, Gandorfer A, Kampik A, Mino De Kaspar H. Application of 10% povidone iodine reduces conjunctival bacterial contamination rate in patients undergoing cataract surgery. European Journal of Ophthalmology. 2012;22(4):541-546. https://doi.org/10.5301/ejo.5000093
Accepte11.01.2021

Close metadata